Cite
HARVARD Citation
Holubar, M. et al. (2022). Favipiravir for Treatment of Outpatients With Asymptomatic or Uncomplicated Coronavirus Disease 2019: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial. Clinical infectious diseases. pp. 1883-1892. [Online].